Responses
Other responses
Jump to comment:
- Published on: 13 April 2016
- Published on: 13 April 2016
- Published on: 13 April 2016Reply to Letter: Which target is best for patients with Parkinson's disease? A meta-analysis of pallidal and subthalamic stimulationShow More
We are pleased that Dr. Cyron agrees with our statement. Although our meta-analysis revealed that depression was more frequent in STN DBS relative to GPi DBS, additional randomized trials which investigate long- term outcome including UPDRS, quality of life and adverse events are required to determine which target is more appropriate for patients with PD. We hope our findings and suggestions would be useful for future stu...
Conflict of Interest:
None declared. - Published on: 13 April 2016STN revistedShow More
This is a timely contribution to an issue overdue. STN-stimulation has been the undisputed mainstay of DBS for Pakinson's disease more than a decade. Reports on deleterious side effects mainly in the field of cognition and emotion however accumulate. While the rather subtle effects on cognitive abilities have been the subject of a plethora of publications, changes in personality and behavior remain underreported. Yet it...
Conflict of Interest:
None declared.